• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲型流感病毒N1神经氨酸酶对二价阳离子需求的差异。

Variation in the divalent cation requirements of influenza A virus N1 neuraminidases.

作者信息

Brett Ian C, Johansson Bert E

机构信息

Department of Pediatrics, Division of Critical Care Medicine, Weill Medical College of Cornell University, 525 East 68th St., New York, NY 10021, USA.

出版信息

J Biochem. 2006 Mar;139(3):439-47. doi: 10.1093/jb/mvj051.

DOI:10.1093/jb/mvj051
PMID:16567409
Abstract

Enzymatic kinetic parameters of influenza A virus N1 neuraminidases (NA) chromatographically purified from several vaccine candidate strains were tested. With ionic strength held constant, Ca2+ or Mg2+ increased the initial rate of enzymatic activity. The 1934 and 1943 strains had statistically significant highest initial velocities, V(max)/K(m) and V(max). There were no significant differences among the influenza virus strains from 1947 to 1991. Measured K(m) for the 1943 strain (6.2 x 10(-5) M) was significantly higher than other strains (3.1-4.7 x 10(-5) M). V(max)/K(m) varied from 0.78 M(-1) s(-1) to 0.91 M(-1) s(-1) and V(max) varied from 3.0 s(-1) to 5.5 s(-1) before the addition of a divalent cation and increased approximately 2-fold for each of these kinetic parameters for each strain after the addition of exogenous Ca2+ or Mg2+. Dialysis reduced the initial velocity and immunogenicity of each strain with significant differences found among strains. Enzymatic activity and immunogenicity were partially restored by the addition of exogenous Ca2+. Nucleic acid sequence analysis could not predict these differences. Selection of vaccine strains must include analysis of antigenic changes, but also enzymatic studies and determination of the requirement of divalent cations to maintain immunogenicity and activity during production.

摘要

对从几种候选疫苗株中通过色谱法纯化得到的甲型流感病毒N1神经氨酸酶(NA)的酶动力学参数进行了测试。在离子强度保持恒定的情况下,Ca2+或Mg2+提高了酶活性的初始速率。1934株和1943株具有统计学上显著最高的初始速度、V(max)/K(m)和V(max)。1947年至1991年的流感病毒株之间没有显著差异。1943株测得的K(m)(6.2×10(-5)M)显著高于其他株(3.1 - 4.7×10(-5)M)。在添加二价阳离子之前,V(max)/K(m)在0.78M(-1)s(-1)至0.91M(-1)s(-1)之间变化,V(max)在3.0s(-1)至5.5s(-1)之间变化,添加外源性Ca2+或Mg2+后,每种菌株的这些动力学参数均增加了约2倍。透析降低了每种菌株的初始速度和免疫原性,各菌株之间存在显著差异。添加外源性Ca2+可部分恢复酶活性和免疫原性。核酸序列分析无法预测这些差异。疫苗株的选择必须包括对抗抗原变化的分析,还包括酶学研究以及确定在生产过程中维持免疫原性和活性所需的二价阳离子。

相似文献

1
Variation in the divalent cation requirements of influenza A virus N1 neuraminidases.甲型流感病毒N1神经氨酸酶对二价阳离子需求的差异。
J Biochem. 2006 Mar;139(3):439-47. doi: 10.1093/jb/mvj051.
2
Variation in the divalent cation requirements of influenza a virus N2 neuraminidases.甲型流感病毒N2神经氨酸酶对二价阳离子需求的变化
J Biochem. 2003 Sep;134(3):345-52. doi: 10.1093/jb/mvg151.
3
Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography.通过免疫层析法估算流感病毒及裂解产物疫苗的神经氨酸酶含量。
Vaccine. 2005 Aug 31;23(37):4598-609. doi: 10.1016/j.vaccine.2005.04.042.
4
Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.使用BIAcore生物传感器分析单克隆抗体NC10的Fab片段与燕鸥和鲸的流感病毒N9神经氨酸酶的结合:固定化水平和流速对动力学分析的影响。
Anal Biochem. 1999 Aug 15;273(1):133-41. doi: 10.1006/abio.1999.4183.
5
[Optimal temperature of enzyme activity and heat resistance of neuraminidases as attenuation markers for influenza viruses].
Boll Ist Sieroter Milan. 1977 Nov 30;56(5):410-7.
6
Complete metal ion requirement of influenza virus N1 neuraminidases. Brief report.
Arch Virol. 1982;71(3):273-7. doi: 10.1007/BF01314879.
7
Influenza virus sialidase: effect of calcium on steady-state kinetic parameters.流感病毒唾液酸酶:钙对稳态动力学参数的影响
Biochim Biophys Acta. 1991 Mar 8;1077(1):65-71. doi: 10.1016/0167-4838(91)90526-6.
8
Influenza A virus neuraminidase: regions of the protein potentially involved in virus-host interactions.甲型流感病毒神经氨酸酶:该蛋白质中可能参与病毒与宿主相互作用的区域。
Virology. 2000 Oct 25;276(2):417-23. doi: 10.1006/viro.2000.0578.
9
[Effect of low pH values on the infectivity and neuraminidase activity of human and animal strains of influenza virus type A].
Acta Biol Med Ger. 1982;41(11):1075-8.
10
Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.在人源和犬源细胞中传代的临床甲型H3N2流感病毒的血凝素(HA)、神经氨酸酶(NA)、非结构蛋白(NS)和基质蛋白(M)基因的结构与进化特征
J Clin Virol. 2009 Aug;45(4):322-33. doi: 10.1016/j.jcv.2009.05.030.

引用本文的文献

1
Anti-neuraminidase immunity in the combat against influenza.抗神经氨酸酶免疫在抗击流感中的作用。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):474-484. doi: 10.1080/14760584.2024.2343689. Epub 2024 Apr 23.
2
The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine.钙和镁对重组N1/N2神经氨酸酶疫苗的活性、免疫原性及效力的影响
NPJ Vaccines. 2021 Apr 6;6(1):48. doi: 10.1038/s41541-021-00310-x.
3
Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection.
抗神经氨酸酶单克隆抗体对 H7N9 流感病毒感染的保护效力。
Emerg Microbes Infect. 2020 Jan 2;9(1):78-87. doi: 10.1080/22221751.2019.1708214. eCollection 2020.
4
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.人类流感感染诱导广泛交叉反应和保护性神经氨酸酶反应性抗体。
Cell. 2018 Apr 5;173(2):417-429.e10. doi: 10.1016/j.cell.2018.03.030.
5
Mutations in NA that induced low pH-stability and enhanced the replication of pandemic (H1N1) 2009 influenza A virus at an early stage of the pandemic.导致低 pH 稳定性的 NA 突变,并在大流行早期增强了大流行(H1N1)2009 流感病毒的复制。
PLoS One. 2013 May 16;8(5):e64439. doi: 10.1371/journal.pone.0064439. Print 2013.
6
Amino acid determinants conferring stable sialidase activity at low pH for H5N1 influenza A virus neuraminidase.在低 pH 值下稳定具有唾液酸酶活性的氨基酸决定簇赋予了 H5N1 流感 A 病毒神经氨酸酶。
FEBS Open Bio. 2012 Sep 5;2:261-6. doi: 10.1016/j.fob.2012.08.007. Print 2012.
7
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.通过用含有2009年大流行H1N1神经氨酸酶的病毒样颗粒对小鼠进行鼻内免疫来抵御致死性H5N1流感病毒攻击。
Virology. 2012 Oct 10;432(1):39-44. doi: 10.1016/j.virol.2012.06.003. Epub 2012 Jun 22.
8
Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.抗神经氨酸酶抗体产生对流感疫苗保护作用的贡献。
Rev Med Virol. 2012 Jul;22(4):267-79. doi: 10.1002/rmv.1713. Epub 2012 Mar 22.
9
Combining crystallographic information and an aspherical-atom data bank in the evaluation of the electrostatic interaction energy in an enzyme-substrate complex: influenza neuraminidase inhibition.在评估酶-底物复合物中的静电相互作用能时结合晶体学信息和非球形原子数据库:流感神经氨酸酶抑制作用
Acta Crystallogr D Biol Crystallogr. 2009 May;65(Pt 5):485-99. doi: 10.1107/S0907444909009433. Epub 2009 Apr 18.